Infectious Diseases News and Research

RSS

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

Even in an economy that's proved devastating to charitable giving and government grants, the Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute (BRI), has managed to buck the trend: BIIR received grants totaling nearly $35 million in 2009.

10 Jun 2010

Differences in immune systems of men and women can impact diseases: Research

In the book Sex Hormones and Immunity to Infection, Sabra Klein, PhD, assistant professor at the Johns Hopkins Bloomberg School of Public Health's W. Harry Feinstone Department of Molecular Microbiology and Immunology, explores the differences in the immune systems of men and women and how these differences can impact disease.

10 Jun 2010

2010 International Conference on Emerging Infectious Diseases at Atlanta, Georgia

Journalists are invited to attend and cover the 2010 International Conference on Emerging Infectious Diseases (ICEID), to be held July 11-14, 2010, at the Hyatt Regency, Atlanta, Georgia. The meeting is being organized by the Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories and the World Health Organization.

10 Jun 2010

Argus Optical Mapping System for microbial whole genome analysis launched at ASM 2010 General Meeting

OpGen, Inc., a microbial genomics solutions company, announced the launch of the Argus Optical Mapping System for microbial whole genome analysis at the ASM 2010 General Meeting held in San Diego, CA May 23-27, 2010. The Argus Optical Mapping System is based on Optical Mapping Technology which generates ordered, whole genome restriction maps from single DNA molecules.

10 Jun 2010

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Researchers at Purdue University have developed a potential new tool for medical diagnostics, testing food and water for contamination, and crime-scene forensics.

9 Jun 2010

Immunosignature technique provides pre-symptomatic diagnosis for broad range of ailments

An inexpensive system for earlier disease diagnosis could save innumerable lives. It would also have a profound impact on the nation's healthcare industry, currently buckling under the strain of spiraling costs.

9 Jun 2010

DSM commences cGMP-manufacturing of Novacta's C. difficile compound

DSM BioSolutions today announced that it has entered into an agreement with Novacta Biosystems Limited, Welwyn Garden City, UK, for the process development and cGMP production of its C. difficile molecule, a new class of lantibiotic compounds.

9 Jun 2010

CMAJ to publish comprehensive new guidelines on immigrant health

CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.

8 Jun 2010

New tool to expedite research ethics review during emergency preparedness

A new emergency review tool will help research ethics boards and institutions to expedite research while respecting the procedures of ethics reviews, states an article in CMAJ.

8 Jun 2010

Updated HIV treatment guidelines may benefit individuals infected with HIV: Researchers

Researchers from the BC Centre for Excellence in HIV/AIDS and the University of British Columbia today released a comprehensive study revealing that the 2008 IAS-USA therapy guidelines for commencing HIV treatment would create significant benefits for individuals infected with HIV and society as a whole.

8 Jun 2010

Ten prevention tips to stay safe from infection and illness during summer camp

As summer sets in, nearly six million campers will attend summer camps in the U.S. And while summer is typically not know as cold or flu season, illnesses and injuries – some very serious – occur every year at hundreds of camps.

7 Jun 2010

Immunome selected as winner of annual New York Venture Summit Top Innovator award

Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.

7 Jun 2010

ASHP honors First DataBank pharmacist with the title of Fellow for excellence in pharmacy practice

First DataBank, a leading provider of drug databases that help drive patient safety, today announced that the American Association of Health-System Pharmacists will honor First DataBank pharmacist Joan Kapusnik-Uner, Pharm.D, with the title of "Fellow" in recognition of the excellence she has achieved in pharmacy practice. The 2010 Fellows will be honored on Tuesday, June 8, 2010, during the ASHP Summer Meeting in Tampa, FL.

7 Jun 2010

CSTE 2010 Annual Conference to focus on public health challenges

The Council of State and Territorial Epidemiologists 2010 Annual Conference will be held June 6-10 at the Oregon Convention Center in Portland, Oregon. An array of experts representing federal, state, and local health departments will discuss issues ranging from last year's flu pandemic, obesity, food safety, health care reform, information technology, and the global response to disasters such as the Haiti earthquake.

5 Jun 2010

Researchers develop biosensors to monitor concentration of c-di-GMP within single living bacteria cells

Some species of bacteria perform an amazing reproductive feat. When the single-celled organism splits in two, the daughter cell - the swarmer - inherits a propeller to swim freely. The mother cell builds a stalk to cling to surfaces.

4 Jun 2010

Scancell's ImmunoBody vaccine technologies to be combined with ImmuneRegen's Homspera

Scancell Holdings Plc, the developer of therapeutic cancer vaccines, today announces a strategic collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc.. Under the agreement, Scancell and ImmuneRegen will work together to investigate the synergy between ImmuneRegen's Homspera® and Scancell's ImmunoBody® vaccine technologies.

4 Jun 2010

Lovastatin protects animals against plague

An experimental study has revealed that lovastatin, a drug prescribed for the treatment of hypercholesterolemia, protects animals against the deadly effects of plague. This infectious disease is on the upsurge in parts of the world. These results obtained by scientists at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (CNRS/Université Aix-Marseille 2) have been published in the journal PLoS ONE.

4 Jun 2010

McMaster University researchers discover chemical clue directing Staphylococcus aureus

McMaster University researchers have discovered a central controller or processing unit of a superbug's weaponry. An article on the breakthrough appears in the high-impact journal Science today.

4 Jun 2010

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Given promptly, the antiviral drug oseltamivir (Tamiflu) appears safe and effective for infants hospitalized with influenza, reports a study in the June issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

4 Jun 2010

Phase 1B clinical study with PMX-60056 meets safety and efficacy endpoints: PolyMedix

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.

3 Jun 2010

Infectious Diseases News and Research

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

Differences in immune systems of men and women can impact diseases: Research

2010 International Conference on Emerging Infectious Diseases at Atlanta, Georgia

Argus Optical Mapping System for microbial whole genome analysis launched at ASM 2010 General Meeting

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Immunosignature technique provides pre-symptomatic diagnosis for broad range of ailments

DSM commences cGMP-manufacturing of Novacta's C. difficile compound

CMAJ to publish comprehensive new guidelines on immigrant health

New tool to expedite research ethics review during emergency preparedness

Updated HIV treatment guidelines may benefit individuals infected with HIV: Researchers

Ten prevention tips to stay safe from infection and illness during summer camp

Immunome selected as winner of annual New York Venture Summit Top Innovator award

ASHP honors First DataBank pharmacist with the title of Fellow for excellence in pharmacy practice

CSTE 2010 Annual Conference to focus on public health challenges

Researchers develop biosensors to monitor concentration of c-di-GMP within single living bacteria cells

Scancell's ImmunoBody vaccine technologies to be combined with ImmuneRegen's Homspera

Lovastatin protects animals against plague

McMaster University researchers discover chemical clue directing Staphylococcus aureus

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Phase 1B clinical study with PMX-60056 meets safety and efficacy endpoints: PolyMedix

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News